You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 021228

✉ Email this page to a colleague

NDA 021228 describes DETROL LA, which is a drug marketed by Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the DETROL LA profile page.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

Summary for 021228

Tradename:	DETROL LA
Applicant:	Upjohn
Ingredient:	tolterodine tartrate
Patents:	0

Pharmacology for NDA: 021228

Mechanism of Action	Cholinergic Muscarinic Antagonists

Medical Subject Heading (MeSH) Categories for 021228

Muscarinic Antagonists
Urological Agents

Suppliers and Packaging for NDA: 021228

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DETROL LA	tolterodine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	021228	NDA	Viatris Specialty LLC	58151-103	58151-103-77	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-103-77)
DETROL LA	tolterodine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	021228	NDA	Viatris Specialty LLC	58151-103	58151-103-93	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-103-93)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE, EXTENDED RELEASE;ORAL			Strength	2MG
Approval Date:	Dec 22, 2000	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE, EXTENDED RELEASE;ORAL			Strength	4MG
Approval Date:	Dec 22, 2000	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021228

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Upjohn	DETROL LA	tolterodine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	021228-002	Dec 22, 2000	5,559,269*PED	⤷ Get Started Free
Upjohn	DETROL LA	tolterodine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	021228-001	Dec 22, 2000	5,382,600*PED	⤷ Get Started Free
Upjohn	DETROL LA	tolterodine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	021228-002	Dec 22, 2000	6,630,162*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.